"Great Plains Health (GPHealth) is driven by a dedicated commitment to our journey from good to great in continual pursuit of excellence in the areas of people, quality, service, growth and finance. To the people of Great Plains Health, excellence is not a destination, but an ongoing journey to get better at what we do every day and in every way. Our journey is intentional, measurable and innovative, as we seek to deliver the very best care possible to the people we serve."

During the past decade, Great Plains Regional Medical Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 19 clinical trials were completed, i.e. on average, 146.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 11 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Great Plains Regional Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 10 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "University of Nebraska" with 3 trials sponsored, "APR Applied Pharma Research s.a." with 2 trials sponsored and "Harmony Biosciences, LLC" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Great Plains Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "United States Department of Defense" with 2 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "Roche-Genentech" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Great Plains Regional Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Breast Cancer" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Colorectal Cancer" (2 trials) and "Idiopathic Hypersomnia" (2 trials). Many other conditions were trialed in "Great Plains Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Great Plains Regional Medical Center" are "Drug" (26 trials), "Other" (14 trials), "Biological" (7 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (8 trials), "Docetaxel" (3 trials), "Placebo" (3 trials), "placebo" (3 trials) and "Bortezomib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Great Plains Regional Medical Center" are 29 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Great Plains Regional Medical Center". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 22 completed trials in Great Plains Regional Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Great Plains Regional Medical Center, 3 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Great Plains Regional Medical Center has several departments that took part in Clinical trials: "Great Plains Health Callahan Cancer Center" - 65 trials